The Food and Drug Administration (FDA) has approved Lumason (sulfur hexafluoride lipid-type A microspheres; Bracco Diagnostics Inc.), an ultrasound enhancing agent, for use in echocardiography to ...

Left ventricular hypertrophy (LVH) is when the heart’s main pumping chamber, the left ventricle, becomes thicker and less able to pump blood efficiently. It usually develops because of another heart ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved perflutren lipid microsphere injection to improve ultrasound imaging in pediatric patients. The ...

Focused cardiac ultrasonography is a point-of-care, qualitative or semiquantitative means of assessing cardiac size, structure, and function that is performed and interpreted by the clinician at the ...

Focused cardiac ultrasonography is a practical, transthoracic, qualitative or semiquantitative means of assessing cardiac size, structure, and function that is performed and interpreted by the ...